MELBOURNE, FL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)PREECLAMPSIA FOUNDATION INC, founded in 2000, is a community nonprofit in the Medical Research sector that reported $5.7M in total revenue in fiscal year 2025. Revenue surged 86% from the prior year, signaling strong growth momentum. The organization ran a surplus of $3.0M, a strong 54% operating margin.
PREECLAMPSIA FOUNDATION: 2025 IMPACT STATEMENT SAVING LIVES AND IMPROVING OUTCOMES FOR MOTHERS AND BABIES IN 2025, THE PREECLAMPSIA FOUNDATION CONTINUED ITS UNWAVERING MISSION TO REDUCE MATERNAL AND INFANT ILLNESS AND DEATH DUE TO HYPERTENSIVE DISORDERS OF PREGNANCY. WITH A CLEAR FOCUS ON HEALTH EQUITY, PATIENT EMPOWERMENT, AND RESEARCH ADVANCEMENT, WE MADE TRANSFORMATIONAL PROGRESS ACROSS ALL FOUR STRATEGIC PILLARS: EDUCATE, ENGAGE, EQUIP, AND ELEVATE. EDUCATE: WE REACHED HUNDREDS OF THOUSANDS OF PATIENTS AND PROFESSIONALS WITH CRITICAL, LIFE-SAVING INFORMATION. OVER 275,800 PATIENT EDUCATION MATERIALS WERE DISTRIBUTED, ARMING FAMILIES WITH THE KNOWLEDGE THEY NEED TO ADVOCATE FOR THEMSELVES. SIMULTANEOUSLY, WE TRAINED MORE THAN 400 HEALTHCARE PROVIDERS AND COMMUNITY HEALTH WORKERS, ENSURING EARLY DETECTION AND PROPER MANAGEMENT OF PREECLAMPSIA IN DIVERSE CLINICAL SETTINGS. ENGAGE: WITH 80 PATIENT-FAMILY PARTNER QUALITY IMPROVEMENT ENGAGEMENTS, WE DEEPENED OUR COMMITMENT TO PATIENT-CEN
COMMUNITY. INCREASE NATIONAL AWARENESS OF PREECLAMPSIA THROUGH EXTENSIVE MEDIA OUTREACH AND AWARENESS EVENTS, INCLUDING RAISING GLOBAL ATTENTION. MAINTAIN THE NUMBER ONE ONLINE PREECLAMPSIA WEBSITE...
COMMUNITY. INCREASE NATIONAL AWARENESS OF PREECLAMPSIA THROUGH EXTENSIVE MEDIA OUTREACH AND AWARENESS EVENTS, INCLUDING RAISING GLOBAL ATTENTION. MAINTAIN THE NUMBER ONE ONLINE PREECLAMPSIA WEBSITE IN THE UNITED STATES, PRODUCE PRINTED AND DIGITAL EDUCATIONAL MATERIALS, UTILIZE MULTIMEDIA AND A PEERTOPEER NETWORK TO PROVIDE EDUCATION AND SUPPORT TO THOSE AFFECTED BY PREECLAMPSIA. PROVIDE A CRISIS WARMLINE FOR PATIENT AND FAMILY SUPPORT, GUIDANCE AND EDUCATION. PROVIDE TRAINING AND CERTIFICATION TO PATIENTS AND FAMILY MEMBERS WHO WISH TO USE THEIR LIVED EXPERIENCE TO POSITIVELY IMPROVE HEALTHCARE PRACTICES, EDUCATION, AND AWARENESS INITIATIVES.
HEALTHCARE PRACTICES. PROVIDE EDUCATION, RESOURCES AND TRAINING FOR HEALTHCARE PROFESSIONALS. ADVOCATE FOR INNOVATIVE PRACTICES WITH HEALTHCARE PROVIDERS, POLICYMAKERS, AND KEY OPINION LEADERS TO...
HEALTHCARE PRACTICES. PROVIDE EDUCATION, RESOURCES AND TRAINING FOR HEALTHCARE PROFESSIONALS. ADVOCATE FOR INNOVATIVE PRACTICES WITH HEALTHCARE PROVIDERS, POLICYMAKERS, AND KEY OPINION LEADERS TO IMPROVE INPATIENT AND OUTPATIENT CARE, SUCH AS PROVIDING BLOOD PRESSURE MONITORS TO PATIENTS DURING PREGNANCY AND THE POSTPARTUM PERIOD AND TRAINING ALL HEALTHCARE PROVIDERS AND FIRST RESPONDERS TO APPROPRIATELY RECOGNIZE, DIAGNOSE AND TREAT POSTPARTUM PATIENTS. TRAIN HEALTHCARE PROVIDERS AND ADMINISTRATORS TO INTEGRATE PATIENT AND FAMILY PERSPECTIVES IN SAFETY AND QUALITY IMPROVEMENT INITIATIVES AT A LOCAL, STATE, AND NATIONAL LEVEL. MEASURE IMPACT OF INTEGRATING LIVED EXPERIENCE IN HEALTHCARE IMPROVEMENT INITIATIVES.
RESEARCH. FUNDS AND ADVOCATES FOR RESEARCH INTO PATHOPHYSIOLOGY, DIAGNOSIS, PREVENTION, AND TREATMENT OF HYPERTENSIVE DISORDERS OF PREGNANCY. PROVIDES RESEARCH FUNDING THROUGH VISION GRANTS, PETER...
RESEARCH. FUNDS AND ADVOCATES FOR RESEARCH INTO PATHOPHYSIOLOGY, DIAGNOSIS, PREVENTION, AND TREATMENT OF HYPERTENSIVE DISORDERS OF PREGNANCY. PROVIDES RESEARCH FUNDING THROUGH VISION GRANTS, PETER JOSEPH PAPPAS RESEARCH FUND, TRAVEL GRANTS TO SCIENTIFIC MEETINGS, AND OTHER RESEARCH PROJECTS. MAINTAINS ONLINE PATIENTLED PREECLAMPSIA RESEARCH REGISTRY AND PROVIDES STUDY PARTICIPANT RECRUITMENT SERVICES. CONDUCT AND PUBLISH PATIENT IMPACT AND CARE PRACTICE RESEARCH STUDIES. ENSURE PATIENTS FROM ALL DIFFERENT BACKGROUNDS HAVE ACCESS TO OPPORTUNITIES TO PARTICIPATE AND ACTIVELY ENGAGE IN PREECLAMPSIA RESEARCH. COLLABORATES WITH RESEARCH SCIENTISTS ON VARIOUS STUDIES AND CROSSLEARNING OPPORTUNITIES.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $5,663,361 | $3,048,206 | +0.9% |
| Expenses | $2,627,991 | $2,627,476 | +0.0% |
| Net Income | $3,035,370 | $420,730 | +6.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ELENI TSIGAS | CEO | 40.00 |
Officer
|
$93,539 | $36,636 | $130,175 |
| ROBYN D'ORIA MA RNC APN | CHAIR | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| FRAN AYALASOMAYAJULA | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| RAKHI DIMINO MD MMM CPE | IMMEDIATE PA | 2.00 |
Director
|
$0 | $0 | $0 |
| RAPHAEL CHARBIT CFA CTP | TREASURER | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| JENNIFER DEYOUNG | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| MELISSA ANNE ANNIE CROSLOW JD | VICE CHAIR | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| JASMINE MAGO | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| SUZANNE MARINELLO | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| TODD MCLAUGHLIN | SECRETARY | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| AKIESHA GILCREST SAINVIL | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $5,663,361 | $2,627,991 | $6,017,039 | $3,035,370 |
| 2024 | No data | No data | No data | No data |
| 2024 | $3,048,206 | $2,627,476 | $3,135,264 | $420,730 |
| 2023 | $2,164,264 | $1,681,501 | $2,346,885 | $482,763 |
| 2022 | $1,582,437 | $1,461,032 | $1,631,500 | $121,405 |
| 2022 | $1,582,437 | $1,461,032 | $1,631,500 | $121,405 |
| 2021 | $1,588,806 | $1,443,521 | $1,762,585 | $145,285 |
| 2021 | $1,588,806 | $1,399,044 | $1,762,585 | $189,762 |
| 2020 | $1,510,355 | $1,206,049 | $1,595,768 | $304,306 |
| 2019 | $1,262,181 | $1,264,720 | $1,117,623 | $-2,539 |
| 2018 | $1,193,901 | $1,230,123 | $1,021,113 | $-36,222 |
Compare PREECLAMPSIA FOUNDATION INC with other nonprofits in Florida and across the country.